CDC Recommends Short Course, Rifamycin-Based Regimens to Treat Latent Tuberculosis Infection

At a glance

Use this graphic on web or social media platforms to encourage health care providers to prescribe short course, rifamycin-based regiments to treat latent tuberculosis (TB) infection.

A health care provider hands a patient a pill bottle. The text reads "CDC recommends short course, rifamycin-based regimens to treat latent TB infection."
Format: JPG
Dimensions: 1200 x 627 pixels
Language: English (US)
Size: 276 KB
View
A health care provider hands a patient a pill bottle. The text reads "CDC recommends short course, rifamycin-based regimens to treat latent TB infection."
Print
Content Source:
About Division of Tuberculosis Elimination; National Center for HIV, Viral Hepatitis, STD, and Tuberculosis Prevention; Centers for Disease Control and Prevention